By ranking the patients according to different parameters like gender, diabetes mellitus, hypertension, cirrhosis, viral load, and FIB4 and APRI scores, we did not find any significant difference, as shown in Table 2, but by ranking patients by eGFR at baseline, serum NGAL was significantly higher in patients with eGFR less than 60 ml/min per 1.73 m2 (667.44 ± 687.43 ng/ml) compared to patients with eGFR 60–89 ml/min per 1.73 m2 (302.85 ± 169.45 ng/ml), or patients with eGFR more than 90 ml/min per 1.73 m2 (258.52 ± 121.02 ng/ml), as shown in Figure 1. This evidence concerns the gene LCN2 and diabetes mellitus.